These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

757 related articles for article (PubMed ID: 37029123)

  • 1. Viral vectored vaccines: design, development, preventive and therapeutic applications in human diseases.
    Wang S; Liang B; Wang W; Li L; Feng N; Zhao Y; Wang T; Yan F; Yang S; Xia X
    Signal Transduct Target Ther; 2023 Apr; 8(1):149. PubMed ID: 37029123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New viral vectors for infectious diseases and cancer.
    Sasso E; D'Alise AM; Zambrano N; Scarselli E; Folgori A; Nicosia A
    Semin Immunol; 2020 Aug; 50():101430. PubMed ID: 33262065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progress on adenovirus-vectored universal influenza vaccines.
    Xiang K; Ying G; Yan Z; Shanshan Y; Lei Z; Hongjun L; Maosheng S
    Hum Vaccin Immunother; 2015; 11(5):1209-22. PubMed ID: 25876176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Large-scale adenovirus and poxvirus-vectored vaccine manufacturing to enable clinical trials.
    Kallel H; Kamen AA
    Biotechnol J; 2015 May; 10(5):741-7. PubMed ID: 25914340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Negative-Strand RNA Virus-Vectored Vaccines.
    Murr M; Mettenleiter T
    Methods Mol Biol; 2024; 2786():51-87. PubMed ID: 38814390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intranasal adenovirus-vectored vaccine for induction of long-lasting humoral immunity-mediated broad protection against influenza in mice.
    Kim EH; Park HJ; Han GY; Song MK; Pereboev A; Hong JS; Chang J; Byun YH; Seong BL; Nguyen HH
    J Virol; 2014 Sep; 88(17):9693-703. PubMed ID: 24920793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel viral vectors in infectious diseases.
    Humphreys IR; Sebastian S
    Immunology; 2018 Jan; 153(1):1-9. PubMed ID: 28869761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Viral vectors as vaccine platforms: from immunogenicity to impact.
    Ewer KJ; Lambe T; Rollier CS; Spencer AJ; Hill AV; Dorrell L
    Curr Opin Immunol; 2016 Aug; 41():47-54. PubMed ID: 27286566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenoviral Vectors as Vaccines for Emerging Avian Influenza Viruses.
    Kerstetter LJ; Buckley S; Bliss CM; Coughlan L
    Front Immunol; 2020; 11():607333. PubMed ID: 33633727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant Newcastle disease virus-vectored vaccines against human and animal infectious diseases.
    Duan Z; Xu H; Ji X; Zhao J
    Future Microbiol; 2015; 10(8):1307-23. PubMed ID: 26234909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chikungunya Virus Vaccines: Viral Vector-Based Approaches.
    Ramsauer K; Tangy F
    J Infect Dis; 2016 Dec; 214(suppl 5):S500-S505. PubMed ID: 27920181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parainfluenza virus 5-vectored vaccines against human and animal infectious diseases.
    Chen Z
    Rev Med Virol; 2018 Mar; 28(2):. PubMed ID: 29316047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunogenicity and efficacy of a chimpanzee adenovirus-vectored Rift Valley fever vaccine in mice.
    Warimwe GM; Lorenzo G; Lopez-Gil E; Reyes-Sandoval A; Cottingham MG; Spencer AJ; Collins KA; Dicks MD; Milicic A; Lall A; Furze J; Turner AV; Hill AV; Brun A; Gilbert SC
    Virol J; 2013 Dec; 10():349. PubMed ID: 24304565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination Adenovirus and Protein Vaccines Prevent Infection or Reduce Viral Burden after Heterologous Clade C Simian-Human Immunodeficiency Virus Mucosal Challenge.
    Malherbe DC; Mendy J; Vang L; Barnette PT; Reed J; Lakhashe SK; Owuor J; Gach JS; Legasse AW; Axthelm MK; LaBranche CC; Montefiori D; Forthal DN; Park B; Wilson JM; McLinden JH; Xiang J; Stapleton JT; Sacha JB; Haynes BF; Liao HX; Ruprecht RM; Smith J; Gurwith M; Haigwood NL; Alexander J
    J Virol; 2018 Jan; 92(2):. PubMed ID: 29093095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Viral vectors for malaria vaccine development.
    Li S; Locke E; Bruder J; Clarke D; Doolan DL; Havenga MJ; Hill AV; Liljestrom P; Monath TP; Naim HY; Ockenhouse C; Tang DC; Van Kampen KR; Viret JF; Zavala F; Dubovsky F
    Vaccine; 2007 Mar; 25(14):2567-74. PubMed ID: 16914237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel alphavirus replicon-vectored vaccine delivered by adenovirus induces sterile immunity against classical swine fever.
    Sun Y; Li HY; Tian DY; Han QY; Zhang X; Li N; Qiu HJ
    Vaccine; 2011 Oct; 29(46):8364-72. PubMed ID: 21888938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaccination with Vesicular Stomatitis Virus-Vectored Chimeric Hemagglutinins Protects Mice against Divergent Influenza Virus Challenge Strains.
    Ryder AB; Nachbagauer R; Buonocore L; Palese P; Krammer F; Rose JK
    J Virol; 2015 Dec; 90(5):2544-50. PubMed ID: 26676789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heterologous prime-boost immunization of Newcastle disease virus vectored vaccines protected broiler chickens against highly pathogenic avian influenza and Newcastle disease viruses.
    Kim SH; Samal SK
    Vaccine; 2017 Jul; 35(33):4133-4139. PubMed ID: 28668574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vector-based genetically modified vaccines: Exploiting Jenner's legacy.
    Ramezanpour B; Haan I; Osterhaus A; Claassen E
    Vaccine; 2016 Dec; 34(50):6436-6448. PubMed ID: 28029542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Viral vectors as vaccine platforms: deployment in sight.
    Rollier CS; Reyes-Sandoval A; Cottingham MG; Ewer K; Hill AV
    Curr Opin Immunol; 2011 Jun; 23(3):377-82. PubMed ID: 21514130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.